The expression of PD-L1 assessed by immunohistochemistry has been shown to correlate with response to ICIs in several tumor types, including non-small cell lung cancer (NSCLC), gastric cancer, and urothelial carcinoma [27,28,29]. Here, CD274 is linked to neoplasm.